PR
Therapeutic Areas
ALKemist Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ALK.CAR-T | ALK+ Neuroblastoma | Preclinical |
| ALK.TCR-T #1 | ALK+ NSCLC | Discovery |
| ALK.TCR-T #2 | ALK+ NSCLC | Discovery |
| Drug | Indication | Phase |
|---|---|---|
| ALK.CAR-T | ALK+ Neuroblastoma | Preclinical |
| ALK.TCR-T #1 | ALK+ NSCLC | Discovery |
| ALK.TCR-T #2 | ALK+ NSCLC | Discovery |